Description
Latin name
Elocom
Release form
cream
Indications
Weakening and elimination of inflammatory phenomena and pruritus in dermatoses, amenable to glucocorticosteroid therapy in adults and children over the age of 2 years.
Contraindications
Hypersensitivity.
Use during pregnancy and lactation
Adequate, well-controlled studies of the teratogenic potential of mometasone furoate when used during pregnancy have not been conducted. The use of cream, ointment or lotion Elokom during pregnancy is possible only if the expected benefits of treatment for the mother will outweigh the potential risk to the fetus.
With systemic use, glucocorticosteroids appear in breast milk, which can lead to a slowdown in the growth of the baby, effects on the endogenous synthesis of glucocorticosteroids and other adverse effects. There is no evidence that systemic absorption of glucocorticosteroids when administered topically can cause their detectable amounts to appear in breast milk. However, due to that many drugs are excreted in breast milk, nursing women should use cream, ointment, Elok lotion with caution.
Ingredients
1 g of cream contains:
Active ingredient: mometasone furoate 1 mg
Excipients: hexylene glycol, phosphoric acid, propylene glycol stearate, stearyl alcohol, cetyl stearyl ether, cetyl diethane, tsetanetenetenetenetenetenetenetetenyltetetenyltetearylate white wax, white petrolatum, purified water.
Dosage and administration
Apply a thin layer to the affected skin 1 time per day.
Side effects of
In controlled clinical trials in 319 patients, the incidence of adverse events associated with the use of Elok cream was 1.6%. Burning, itching, skin atrophy there have been reports of the appearance of rosacea. In controlled clinical trials in children aged 2 to 12 years (n = 74), the frequency of adverse events (burning, itching, furunculosis) associated with the use of cream was approximately 7%.
No drug interaction
No data available.
Overdose
When used topically in large doses, it is possible to absorb the drug in quantities sufficient to show systemic side effects.
Storage conditions
The drug should be stored at a temperature of 2 to 25 ° C.
Expiration
2 years.
Action schee substances
mometasone
Dosage form
Dosage form srdlk p cream
